Lupin Foundation bags CRISIL's Highest VO 1A rating for Excellence in Social Responsibility
This distinction is testament to LHWRF's dedication to excellence, transparency, and impact in the realm of social responsibility
This distinction is testament to LHWRF's dedication to excellence, transparency, and impact in the realm of social responsibility
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
India presents one of the world’s largest untapped opportunities for neurovascular screening
Subscribe To Our Newsletter & Stay Updated